ArticleExperimental & molecular medicine2019

C-type natriuretic peptide attenuates renal osteodystrophy through inhibition of FGF-23/MAPK signaling.

Dong Dong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.